Anthony Fauci, Director of the NIH National Institute for Allergies and Infectious Diseases will address the daily meeting for the White House in Washington, January 21, 2021.
Jonathan Ernst | Reuters
AstraZeneca is likely to release a revised report on the Covid-19 vaccine after the accuracy of the company’s clinical trial results was questioned earlier in the week, a Chief Adviser said White House Medical, Dr. Anthony Fauci said Wednesday.
The company on Monday announced the long-awaited results of the phase three clinical trial of the Covid-19 vaccine it developed with Oxford University, saying it was 79% effective in preventing symbolic illness and 100% effective against serious disease and hospitalization.
The next day, the National Institute of Infectious Diseases and Infectious Diseases released a bizarre statement that was told by the data and safety review board, or DSMB, which was monitoring the lawsuit that its UK-based company has imported information into the US. results that provided an “incomplete view of the efficiency data.”
Fauci, director of NIAID, said the DSMB raised concerns with the U.S. agency because it felt the results in an AstraZeneca press release looked more favorable than more recent data from the vaccine study showed, according to STAT News .
The company is now working with the DSMB and “may come out with a revised statement,” Fauci told reporters Wednesday at a White House press conference about the pandemic.
Public health and vaccination experts told CNBC that the AstraZeneca data pull is just the latest example in a series of blunders by the company that could affect people’s willingness to take the vaccine, which could be authorized for use in the US as early as next month.
President Joe Biden ‘s chief adviser on the pandemic, Andy Slavitt, tried to reassure Americans about the vaccines on Tuesday, telling CNN, “The public should be sure not to approval unless the FDA carefully examines this data. “
When the AstraZeneca vaccine goes through an FDA review, the agency will “judge both what the data says, or what it says, and also whether or not it will be accepted. And so until then, this is just material that will make that happen in the background, “Slavitt said.” We believe that this transparency and scientific independence is crucial for public confidence. “
AstraZeneca vaccine is already authorized for use in other countries. The company said in a statement Tuesday that it expected to release results from its main study of the Covid-19 vaccine “within 48 hours.”